2022 HFSA AHFTC Board Review

Content:

Day 1

Session 1 : Cardiac Transplantation

• -Welcome and HFSA Introduction
  Akshay Desai, MD, MPH, FHFSA
  John Barnes, HFSA CEO
• -Advanced Heart Failure: Defining the Phenotype and
  Patient Selection for Advanced Therapies (with LIVE
  Q&A)
  Nancy Sweitzer, MD, PhD, FHFSA
• -Immunology: The Basics, PRA, Sensitization,
  Crossmatch( PDF)
  Sean Pinney, MD
• LIVE Q&A:
  -Managing Immunosuppression and Drugs
  -Heart Transplant, Clinical Outcomes and Complications
  Michelle Kittleson, MD, PhD
• -Heart Transplant, Clinical Outcomes and Complications
  Michelle Kittleson, MD, PhD

Day 2

-Welcome and Introductions (LIVE)
Akshay Desai, MD, MPH, FHFSA

SESSION II: Key Issues in HF Management (Part I)

• -Hemodynamics in HF II (with LIVE Q&A)
  James C. Fang, MD, FHFSA
• -Optimal Medical Therapy for HFrEF (1)
  Mark Drazner, MD, MSc, FHFSA
• -Optimal Medical Therapy for HFrEF (2)
  Mark Drazner, MD, MSc, FHFSA
• -LIVE Q&A:
  -Optimal Medical Therapy for HFrEF
  Mark Drazner, MD, MSc, FHFSA
• -HFpEF: Epidemiology, Risk Factors, Diagnosis,
  Management – for the boards (with LIVE Q&A)
  Sanjiv Shah, MD

SESSION II: Key Issues in HF Management (Part II)

• -Management of the Hospitalized HF Patient
  Maria Rosa Costanzo, MD
• -Pulmonary Hypertension – Therapy (with LIVE Q&A)
  Jonathan Rich, MD, FHFSA
• -Management of Common Arrhythmias – Atrial Fib and
  Flutter
  Roderick Tung, MD
• -LIVE Q&A:
  -Management of Common Arrhythmias I – Atrial Fib and
  Flutter
  -Management of Common Arrhythmias II
  Roderick Tung, MD
• -Device Therapy in Heart Failure I – Sudden Death
  Prevention
  Wendy Tzou, MD, FACC, FHRS
• -Device Therapy in Heart Failure II – CRT
  Wendy Tzou, MD, FACC, FHRS
• -LIVE Q&A:
  -Device Therapy in Heart Failure I – Sudden Death
  Prevention
  -Device Therapy in Heart Failure II – CRT
  Wendy Tzou, MD, FACC, FHRS

SESSION II: Key Issues in HF Management (Part III)

• -Management of Comorbidities in Heart Failure – Iron
  Deficiencies/Anemia (with LIVE Q&A)
  Maria Rosa Costanzo, MD
• -Cardio Renal Failure Interactions in Heart Failure
  (with LIVE Q&A)
  Jeff Testani, MD, MTR

SESSION III: Specific Heart Failure Syndromes

• -Specific Etiologies of HF I: Common Etiologies – CAD,
  ETOH, Peripartum, Myocarditis (with LIVE Q&A)
  Akshay Desai, MD, MPH, FHFSA
• -Specific Etiologies of HF II: Inherited HF syndromes
  including HCM, ARVC, and LVNC (with LIVE Q&A)
  Jane Wilcox, MD, MSc, FHFSA
• -Specific Etiologies of HF III: Infiltrative Disorders
  and Restrictive Cardiomyopathy – Amyloidosis,
  Sarcoidosis, Hemochromatosis, Fabry (with LIVE Q&A)
  Sanjiv Shah, MD
• -Q&A Faculty Panel – Day 2
• Q&A Faculty Panel
  Program Co-Chairs

Day 3

-Welcome and Introductions (LIVE)
Akshay Desai, MD, MPH, FHFSA

SESSION IV: Shock/MCS

• -Cardiogenic Shock Management (with LIVE Q&A)
  Nancy Sweitzer, MD, PhD, FHFSA
• -MCS I: Durable MCS Devices and Outcomes (with LIVE
  Q&A)
  Joseph Rogers, MD
• -MCS II: Temporary Support Devices and ECMO for the
  Boards
  Jennifer Cowger, MD, MS
• -LIVE Q&A
• MCS IV: Interactive Shock and Device Management (Note:
  Live Session)
  Daniel Burkhoff, MD, PhD
  Jennifer Cowger, MD, MS
  Joseph Rogers, MD
  Nancy Sweitzer, MD, PhD, FHFSA

SESSION V: Special Topics in HF

• -Assessment of Functional Capacity including
  Cardiopulmonary Exercise Testing (with LIVE Q&A)
  Gregory Lewis, MD
• -Healthcare Disparities in HF (with LIVE Q&A)
  Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA
• -Issues in Chronic HF Disease Management – Biomarkers,
  Remote Monitoring, Lifestyle Interventions (with LIVE
  Q&A)
  Akshay Desai, MD, MPH, FHFSA
• -Management of Left Sided Valvular Heart Disease in
  Heart Failure including Functional MR, Low Gradient AS
  (with LIVE Q&A)
  Jane Wilcox, MD, MSc, FHFSA
• -Adult Congenital Heart Disease for the HF Specialist
  (with LIVE Q&A)
  Eric Krieger, MD
• Q&A Faculty Panel – Day 3
• -Q&A Faculty Panel
• Program Co-Chairs

————-
Heart Failure Fundamentals

• -Heart Failure Epidemiology and Risk Factors
  -Pathophysiology I: Cellular and Energetic onsideration
  -Pathophysiology II: Hemodynamic, Structural, and
  Neurohormonal Considerations
  -Diagnosis and Clinical Assessment
  -Cardio-Oncology for the Heart Failure Boards
  – Clinico-Pathologic Correlates in Heart Failure Images
  for the Heart Failure Boards
  -Statistics for the HF Board
  -Hemodynamics in Heart Failure
  -Pulmonary (arterial) hypertension:Classification and
  Evaluation
  -Comorbidities in Heart Failure: Focus on Diabetes and
  COPD
  -RV Failure and TR Management
  -Management of Comorbidities in Heart Failure – Sleep
  Disorder